Vitamin D metabolites are essential for bone regeneration and mineral homeostasis. The vitamin D precursor 7-dehydrocholesterol can be used after UV irradiation to locally produce active vitamin D by osteoblastic cells. Furthermore, UV-irradiated 7-dehydrocholesterol is a biocompatible coating for titanium implants with positive effects on osteoblast differentiation. In this study, we examined the impact of titanium implants surfaces coated with UV-irradiated 7-dehydrocholesterol on the osteogenic differentiation of human umbilical cord mesenchymal stem cells. First, the synthesis of cholecalciferol (D3) was achieved through the incubation of the UV-activated 7-dehydrocholesterol coating for 48 h at 23℃. Further, we investigated in vitro the biocompatibility of this coating in human umbilical cord mesenchymal stem cells and its potential to enhance their differentiation towards the osteogenic lineage. Human umbilical cord mesenchymal stem cells cultured onto UV-irradiated 7-dehydrocholesterol-coated titanium implants surfaces, combined with osteogenic supplements, upregulated the gene expression of several osteogenic markers and showed higher alkaline phosphatase activity and calcein blue staining, suggesting increased mineralization. Thus, our results show that the use of UV irradiation on 7-dehydrocholesterol -treated titanium implants surfaces generates a bioactive coating that promotes the osteogenic differentiation of human umbilical cord mesenchymal stem cells, with regenerative potential for improving osseointegration in titanium-based bone anchored implants.
HewisonMBurkeFEvansKN. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol2007; 103: 316–321.
4.
SatuéMCórdobaARamisJM. UV-irradiated 7-dehydrocholesterol coating on polystyrene surfaces is converted to active vitamin D by osteoblastic MC3T3-E1 cells. Photochem Photobiol Sci2013; 12: 1025–1035.
5.
SatuéMPetzoldCCórdobaA. UV photoactivation of 7-dehydrocholesterol on titanium implants enhances osteoblast differentiation and decreases Rankl gene expression. Acta Biomater2013; 9: 5759–5770.
6.
MusinaRABekchanovaESBelyavskiiAV. Differentiation potential of mesenchymal stem cells of different origin. Bull Exp Biol Med2006; 141: 147–151.
7.
KlingemannHMatzilevichDMarchandJ. Mesenchymal stem cells – sources and clinical applications. Transfus Med Hemother2008; 35: 272–277.
8.
SalemHKThiemermannC. Mesenchymal Stromal Cells: current understanding and clinical Status. Stem cells2010; 28: 585–596.
9.
Da Silva MeirellesLChagastellesPCNardiNB. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci2006; 119: 2204–2213.
10.
CanAKarahuseyinogluS. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem cells2007; 25: 2886–2895.
11.
In’t AnkerPSScherjonSa, Kleijburg-van der KeurC. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem cells2004; 22: 1338–1345.
12.
KonEMuragliaACorsiA. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mat Res A2000; 49: 328–337.
13.
BruderSPJaiswalNRicaltonNS. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res1998; 355(Suppl): S247–S256.
14.
HorwitzEMGordonPLKooWK. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA2002; 99: 8932–8937.
15.
KramperaMPizzoloGApriliGFM. Mesenchymal stem cells for bone, cartilage, tendon and skeletal muscle repair. Bone2006; 39: 678–683.
16.
LiuPOyajobiBORussellRG. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) in vitro. Calcified Tissue Int1999; 65: 173–180.
17.
JørgensenNRHenriksenZSørensenOH. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids2004; 69: 219–226.
18.
BeresfordJNJoynerCJDevlinC. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol1994; 39: 941–947.
19.
RamisJMRubertMVondrasekJ. Effect of enamel matrix derivative and of proline-rich synthetic peptides on the differentiation of human mesenchymal stem cells toward the osteogenic lineage. Tissue Eng Part A2012; 18: 1253–1263.
20.
PfafflMW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res2001; 29: e45–e45.
21.
PfafflMWTichopadAPrgometC. Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper–Excel-based tool using pair-wise correlations. Biotechnol Lett2004; 26: 509–515.
22.
GotoTKajiwaraHYoshinariM. In vitro assay of mineralized-tissue formation on titanium using fluorescent staining with calcein blue. Biomaterials2003; 24: 3885–3892.
23.
HowardGATurnerRTSherrardDJ. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3. J Biol Chem1981; 256: 7738–7740.
24.
GengSZhouSBiZ. Vitamin D metabolism in human bone marrow stromal (mesenchymal stem) cells. Metab Clin Exp2013; 62: 768–777.
25.
KellyJLinAWangCJ. Vitamin D and bone physiology: demonstration of vitamin D deficiency in an implant osseointegration rat model. J Prosthodont2009; 18: 473–478.
26.
DvorakGFüglAWatzekG. Impact of dietary vitamin D on osseointegration in the ovariectomized rat. Clin Oral Implants Res2012; 23: 1308–1313.
27.
PasseriGVescoviniRSansoniP. Calcium metabolism and vitamin D in the extreme longevity. Exp Gerontol2008; 43: 79–87.
28.
ZhouWLangsetmoLBergerC. Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian multicentre osteoporosis study (CaMos). J Musculoskelet Neuronal Interact2013; 13: 470–479.
29.
Gaffney-StombergELutzLJRoodJC. Calcium and vitamin D supplementation maintains parathyroid hormone and improves bone density during initial military training: a randomized, double-blind, placebo controlled trial. Bone2014; 68: 46–56.
30.
MacLaughlinJAAndersonRRHolickMF. Spectral character of sunlight modulates photosynthesis of previtamin D3 and its photoisomers in human skin. Science1982; 216: 1001–1003.
31.
HolickMF. The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol1981; 77: 51–58.
32.
Holick MF. Vitamin D: physiology, molecular biology, and clinical applications. New York, NY: Humana Press, 2010.
33.
DeschaseauxFSensébéLHeymannD. Mechanisms of bone repair and regeneration. Trends Mol Med2009; 15: 417–429.
34.
BielbyRJonesEMcGonagleD. The role of mesenchymal stem cells in maintenance and repair of bone. Injury2007; 38(Suppl 1): S26–S32.
35.
JaiswalNHaynesworthSECaplanAI. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem1997; 64: 295–312.
36.
LiuPOyajobiBORussellRG. Regulation of osteogenic differentiation of human bone marrow stromal cells: interaction between transforming growth factor-beta and 1,25(OH)(2) vitamin D(3) In vitro. Calcified Tissue Int1999; 65: 173–180.
37.
PiekESleumerLSvan SomerenEP. Osteo-transcriptomics of human mesenchymal stem cells: accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone2010; 46: 613–627.
38.
ZhouSGlowackiJKimSW. Clinical characteristics influence in vitro action of 1,25-Dihydroxyvitamin D3 in human marrow stromal cells. Connect Tissue Res2012; 27: 1992–2000.
39.
MansellJPBlackburnJ. Lysophosphatidic acid, human osteoblast formation, maturation and the role of 1α,25-Dihydroxyvitamin D3 (calcitriol). Biochim Biophys Acta2013; 1831: 105–108.
40.
JurutkaPWBartikLWhitfieldGK. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands. J Bone Miner Res2007; 22(Suppl 2): V2–V10.
41.
ParedesRArriagadaGCruzatF. Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol2004; 24: 8847–8861.
42.
Zur NiedenNIKempkaGAhrHJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation2003; 71: 18–27.
43.
D’IppolitoGSchillerPCPerez-stableC. Cooperative actions of hepatocyte growth factor and 1,25-dihydroxyvitamin D3 in osteoblastic differentiation of human vertebral bone marrow stromal cells. Bone2002; 31: 269–275.
44.
ChenKPerez-StableCD’IppolitoG. Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27. Bone2011; 49: 1194–1204.
45.
KraichelyDMMacDonaldPN. Transcriptional activation through the vitamin D receptor in osteoblasts. Front Biosci1998; 3: d821–d833.
46.
Olivares-NavarreteRSuthaKHyzySL. Osteogenic differentiation of stem cells alters vitamin D receptor expression. Stem Cells Dev2012; 21: 1726–1735.
47.
LiJJKimRHZhangQ. Characteristics of vitamin D3 receptor (VDR) binding to the vitamin D response element (VDRE) in rat bone sialoprotein gene promoter. Eur J Oral Sci1998; 106(Suppl): 408–417.
48.
ShenQChristakosS. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem2005; 280: 40589–40598.
49.
BeresfordJNJoynerCJDevlinC. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol1994; 39: 941–947.
50.
Van DrielMKoedamMBuurmanCJ. Evidence that both 1alpha, 25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem2006; 99: 922–935.
